Calcium Phosphate
Brand names: Enbrace Hr · Active ingredient: Levomefolate Magnesium
In short: EnBrace HR® is indicated in the TREATMENT of vitamin deficiency - specifically vitamin B12 deficiency - and TREATMENT of hyperhomocysteinemia due to vitamin B12 and/or folate deficiency, and the PREVENTION of deficiency of the vitamin B12 cofactor, l-methylfolate. Requirements of vitamin B9 and/or v
What is Calcium Phosphate used for?
EnBrace HR®
is indicated in the TREATMENT of vitamin deficiency - specifically vitamin B12 deficiency - and TREATMENT of hyperhomocysteinemia due to vitamin B12 and/or folate deficiency, and the PREVENTION of deficiency of the vitamin B12 cofactor, l-methylfolate.
Requirements of vitamin B9 and/or vitamin B12 in excess of normal due to pregnancy can usually be met with oral supplementation.
Calcium Phosphate dosage
The recommended dosage is one (1) capsule daily, preferably on an empty stomach. Dosage may be adjusted by a healthcare provider based on individual patient needs.
As a general rule reticulocyte plasma count, folate and vitamin B12 status must be obtained prior to treatment.
Do not exceed the recommended dose. Call your medical practitioner about side effects. You may report side effects by calling (866) 280-5961.
Warnings & precautions
GENERAL:
0.1 mg or more of folic acid daily may obscure pernicious anemia in that the hematological remission may occur while neurological manifestations remain progressive. The safe tolerable limit for folic acid (in preparations) is 1 mg [emphasis added].
Folic acid is not a substitute for vitamin B12 - although it may improve vitamin B12-deficient megaloblastic anemia. Exclusive use of folic acid in treating vitamin B12-deficient megaloblastic anemia could result in progressive and irreversible neurologic damage. Specifically, vitamin B12 deficiency allowed to progress over 3 months may produce permanent degenerative lesions of the spinal cord - as observed when folate therapy is used as the only hematopoietic agent.
Doses of vitamin B12 exceeding 10 mcg daily may produce hematologic response in patients with folate deficiency. Indiscriminate administration may mask the true diagnosis.
A dietary deficiency of only vitamin B12 is rare; multiple vitamin deficiency is expected in any dietary deficiency. No single regimen fits all cases, and the status of the patient observed in follow-up is the final criterion for adequacy of therapy.
DRUG INTERACTIONS:
Colchicine, para-aminosalicylic acid, and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY:
There is no evidence from long-term use in patients with pernicious anemia that vitamin B12 or folate is carcinogenic. Pernicious anemia is associated with increased incidence of carcinoma of the stomach, but this is believed to be related to the underlying pathology and not to treatment with vitamin B12.
PREGNANCY, NURSING MOTHERS, PEDIATRIC USE:
Vitamin B9 and vitamin B12 are essential vitamins and requirements are increased during pregnancy. …
Calcium Phosphate side effects
Mild transient diarrhea, polycythemia vera, itching, transitory exanthema, feeling of swelling of entire body may occur with administration of vitamin B12.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
About this medicine
EnBrace HR® is an orally administered prescription anti-anemia preparation and prenatal vitamin softgel for therapeutic use, formulated for adult patients, to be used under the supervision of a licensed medical practitioner. A clinical trial+ evaluated EnBrace HR® in women trying to conceive or in early pregnancy who had a history of depression and were undergoing treatment for it.
+ ClinicalTrials.gov identifier: NCT02676882, "EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy"; Sponsor: Massachusetts General Hospital.
EnBrace HR® contains a small amount of iron and may be taken concurrently with iron supplementation.
Folic acid, DHF+ (B9-Provitamin) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (1.7 mg DFE) 1 mg
Folinic acid (B9-vitamer). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (4.25 mg DFE) 2.5 mg
Levomefolic acid (B9 & B12- cofactor) . . . . . . . . . . . . . . . . . . . . . . . . . . (9 mg DFE) 5.23 mg
Vitamin B12 [cobamamide] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 6f14fa40-97ab-4ec5-b66b-793d6d1abac9. Read the full official label on DailyMed.